Recent Finacing
Recent Raise
RenovoRx develops catheter-based drug‑device systems—RenovoCath and TAMP—to deliver localized intra‑arterial chemotherapy (RenovoGem) for pancreatic and solid tumors, evaluated in Phase III TIGeR‑PaC with OS, safety, and quality‑of‑life endpoints.
